Literature DB >> 19353385

A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls.

Ryota Hashimoto1, Hiroko Noguchi, Hiroaki Hori, Tetsuo Nakabayashi, Tatsuyo Suzuki, Nakao Iwata, Norio Ozaki, Asako Kosuga, Masahiko Tatsumi, Kunitoshi Kamijima, Seiichi Harada, Masatoshi Takeda, Osamu Saitoh, Hiroshi Kunugi.   

Abstract

Schizophrenia is a common psychiatric disorder characterized by disturbances of cognition, emotion and social functioning. There are few studies investigating a possible genetic basis for the underlying mechanism of cognitive dysfunctions. A genetic variation in the dysbindin gene (DTNBP1: dystrobrevin binding protein 1), a susceptibility gene for schizophrenia, has been reported to be associated with general cognitive ability and cognitive decline in patients with schizophrenia. Although profound disturbances of memory performance are observed in schizophrenia, only one study has reported a relationship between this gene and spatial working memory in a Caucasian population. We examined a possible association between a protective haplotype of DTNBP1 for developing schizophrenia and memory performance measured by the Wechsler Memory Scale-Revised (WMS-R) and the Wechsler Adult Intelligence Scale-Revised (WAIS-R) in 165 healthy volunteers and 70 patients with schizophrenia in a Japanese population. Healthy controls that carry the protective haplotype showed higher performance in several memory domains measured by the WMS-R than those who did not. Genotype effect on memory performance was not observed in patients with schizophrenia. This haplotype did not affect IQ and its sub-scores as measured by the Wechsler Adult Intelligence Scale-Revised in both groups. These data suggest that DTNBP1 may have impact on parts of memory functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19353385     DOI: 10.1080/15622970902736503

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  14 in total

1.  Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila.

Authors:  Lisha Shao; Yichun Shuai; Jie Wang; Shanxi Feng; Binyan Lu; Zuo Li; Yukai Zhao; Lianzhang Wang; Yi Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-02       Impact factor: 11.205

2.  Meta-analysis of genetic variation in DTNBP1 and general cognitive ability.

Authors:  Jian-Ping Zhang; Katherine E Burdick; Todd Lencz; Anil K Malhotra
Journal:  Biol Psychiatry       Date:  2010-12-15       Impact factor: 13.382

Review 3.  Contribution of nonprimate animal models in understanding the etiology of schizophrenia.

Authors:  Noah L Lazar; Richard W J Neufeld; Donald P Cain
Journal:  J Psychiatry Neurosci       Date:  2011-07       Impact factor: 6.186

4.  The effects of a DTNBP1 gene variant on attention networks: an fMRI study.

Authors:  Markus Thimm; Axel Krug; Thilo Kellermann; Valentin Markov; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Markus M Nöthen; Marcella Rietschel; Tilo Kircher
Journal:  Behav Brain Funct       Date:  2010-09-16       Impact factor: 3.759

5.  COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Kenneth Cheung; Arshi K Arora; Maria Kryza-Lacombe; Youming Xu; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neuro Oncol       Date:  2016-04-18       Impact factor: 12.300

6.  Reduced rate of neural differentiation in the dentate gyrus of adult dysbindin null (sandy) mouse.

Authors:  Naomi Nihonmatsu-Kikuchi; Ryota Hashimoto; Satoko Hattori; Shinsuke Matsuzaki; Takiko Shinozaki; Haruka Miura; Shigeru Ohota; Masaya Tohyama; Masatoshi Takeda; Yoshitaka Tatebayashi
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

7.  Correlated alterations in serotonergic and dopaminergic modulations at the hippocampal mossy fiber synapse in mice lacking dysbindin.

Authors:  Katsunori Kobayashi; Satomi Umeda-Yano; Hidenaga Yamamori; Masatoshi Takeda; Hidenori Suzuki; Ryota Hashimoto
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

8.  Behavioral characterization of mice overexpressing human dysbindin-1.

Authors:  Norihito Shintani; Yusuke Onaka; Ryota Hashimoto; Hironori Takamura; Tsuyoshi Nagata; Satomi Umeda-Yano; Akihiro Mouri; Takayoshi Mamiya; Ryota Haba; Shinsuke Matsuzaki; Taiichi Katayama; Hidenaga Yamamori; Takanobu Nakazawa; Kazuki Nagayasu; Yukio Ago; Yuki Yagasaki; Toshitaka Nabeshima; Masatoshi Takeda; Hitoshi Hashimoto
Journal:  Mol Brain       Date:  2014-10-09       Impact factor: 4.041

9.  Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals.

Authors:  Hiroaki Hori; Noriko Yamamoto; Takashi Fujii; Toshiya Teraishi; Daimei Sasayama; Junko Matsuo; Yumiko Kawamoto; Yukiko Kinoshita; Miho Ota; Kotaro Hattori; Masahiko Tatsumi; Kunimasa Arima; Hiroshi Kunugi
Journal:  Sci Rep       Date:  2012-09-06       Impact factor: 4.379

10.  Association of the Hermansky-Pudlak syndrome type 4 (HPS4) gene variants with cognitive function in patients with schizophrenia and healthy subjects.

Authors:  Go Kuratomi; Atsushi Saito; Yuji Ozeki; Takashi Watanabe; Kumiko Fujii; Kazutaka Shimoda; Toshihiko Inukai; Harunobu Mori; Kenichi Ohmori; Kazufumi Akiyama
Journal:  BMC Psychiatry       Date:  2013-10-30       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.